Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Sensitive monitoring of acute promyelocytic leukemia by PML-RARA DNA Q-PCR.

Kommers IO, Bartley PA, Budgen B, Latham S, Beligaswatte A, Supple SG, Catalano A, Iland HJ, Morley AA, Ross DM.

Leuk Lymphoma. 2017 Jul;58(7):1767-1769. doi: 10.1080/10428194.2016.1262033. Epub 2016 Nov 30. No abstract available.

PMID:
27899039
2.

Atypical presentation of therapy-related acute promyelocytic leukaemia with marrow fibrosis.

Mohamed M, Iland HJ, Sharma S, Supple SG.

Pathology. 2016 Apr;48(3):286-8. doi: 10.1016/j.pathol.2016.02.012. Epub 2016 Mar 9. No abstract available.

PMID:
27020510
3.

Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial.

Iland HJ, Collins M, Bradstock K, Supple SG, Catalano A, Hertzberg M, Browett P, Grigg A, Firkin F, Campbell LJ, Hugman A, Reynolds J, Di Iulio J, Tiley C, Taylor K, Filshie R, Seldon M, Taper J, Szer J, Moore J, Bashford J, Seymour JF; Australasian Leukaemia and Lymphoma Group.

Lancet Haematol. 2015 Sep;2(9):e357-66. doi: 10.1016/S2352-3026(15)00115-5. Epub 2015 Aug 20.

PMID:
26685769
4.

All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).

Iland HJ, Bradstock K, Supple SG, Catalano A, Collins M, Hertzberg M, Browett P, Grigg A, Firkin F, Hugman A, Reynolds J, Di Iulio J, Tiley C, Taylor K, Filshie R, Seldon M, Taper J, Szer J, Moore J, Bashford J, Seymour JF; Australasian Leukaemia and Lymphoma Group.

Blood. 2012 Aug 23;120(8):1570-80; quiz 1752. Epub 2012 Jun 19.

5.

Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases.

Heinrich MC, Joensuu H, Demetri GD, Corless CL, Apperley J, Fletcher JA, Soulieres D, Dirnhofer S, Harlow A, Town A, McKinley A, Supple SG, Seymour J, Di Scala L, van Oosterom A, Herrmann R, Nikolova Z, McArthur AG; Imatinib Target Exploration Consortium Study B2225.

Clin Cancer Res. 2008 May 1;14(9):2717-25. doi: 10.1158/1078-0432.CCR-07-4575.

6.

White matter abnormalities on MRI in neuroacanthocytosis.

Nicholl DJ, Sutton I, Dotti MT, Supple SG, Danek A, Lawden M.

J Neurol Neurosurg Psychiatry. 2004 Aug;75(8):1200-1. No abstract available.

7.

A spontaneous novel XK gene mutation in a patient with McLeod syndrome.

Supple SG, Iland HJ, Barnett MH, Pollard JD.

Br J Haematol. 2001 Nov;115(2):369-72.

PMID:
11703337

Supplemental Content

Loading ...
Support Center